Biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothers

Background: Biotin is the coenzyme of multiple carboxylases involved in gluconeogenesis, fatty acid synthesis, and amino acid catabolism. Biotinidase (BTD) deficiency is an autosomal recessive disorder affecting the biotin cycle. It disrupts endogenous biotin recycling and results in multiple carbox...

Full description

Bibliographic Details
Main Authors: Ranjana Mishra, Meenakshi Bothra Gupta, Sharmila B Mukherjee, Avinash Lomash, Sangeeta Gupta, Seema Kapoor
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Pediatrics Case Reports
Subjects:
Online Access:http://www.ipcares.org/article.asp?issn=2772-5170;year=2022;volume=2;issue=1;spage=12;epage=16;aulast=Mishra
_version_ 1797245428980252672
author Ranjana Mishra
Meenakshi Bothra Gupta
Sharmila B Mukherjee
Avinash Lomash
Sangeeta Gupta
Seema Kapoor
author_facet Ranjana Mishra
Meenakshi Bothra Gupta
Sharmila B Mukherjee
Avinash Lomash
Sangeeta Gupta
Seema Kapoor
author_sort Ranjana Mishra
collection DOAJ
description Background: Biotin is the coenzyme of multiple carboxylases involved in gluconeogenesis, fatty acid synthesis, and amino acid catabolism. Biotinidase (BTD) deficiency is an autosomal recessive disorder affecting the biotin cycle. It disrupts endogenous biotin recycling and results in multiple carboxylase deficiency depending upon the level of enzyme activity. Children with profound deficiency often present in infancy with neurocutaneous manifestations. Management of symptomatic children or screen-positive newborns is lifelong oral supplementation with biotin. There may be partial or complete resolution of symptoms in the former. Clinical Description: We describe two unrelated families diagnosed as profound BTD deficiency, with three affected children in each family. The first family had two symptomatic surviving children, a 2-year-old boy with seizures, developmental delay, and hearing loss, and a 1.5-month-old boy with seizures. Diagnosis was established while ascertaining etiology for seizures refractory to multiple anticonvulsant therapy. The second family was referred for postconceptional counseling following two infantile deaths with similar phenotype, early-onset seizures, encephalopathy, and acute metabolic decompensation. Management: The affected children in the first family showed a dramatic response in seizure controls with oral biotin though the other symptoms such as developmental delay and hearing loss remained unaffected. Mother was advised regarding prenatal diagnosis in the next pregnancy but was unwilling. In the second family, stored genetic material from the earlier affected infant revealed a pathogenic homozygous indel in the BTD gene, which was confirmed in utero in the subsequent pregnancy. Both women were started on oral biotin on the lines of antenatal management of holocarboxylase synthetase deficiency. After birth, therapy was continued on the confirmation of profound BTD deficiency in both babies. They have remained asymptomatic on follow-up; the first baby till a year and the second till 3 months. Conclusion: There is a considerable phenotypic variability in profound BTD deficiency. Early detection and prompt treatment with biotin may result in complete resolution of some symptoms and ameliorate others. Antenatal biotin supplementation in families at high risk or with prenatal diagnosis of BTD deficiency may have a favorable outcome in affected progeny.
first_indexed 2024-04-24T19:26:45Z
format Article
id doaj.art-9f5d2279a3e3415fadad0b1981120860
institution Directory Open Access Journal
issn 2772-5170
2772-5189
language English
last_indexed 2024-04-24T19:26:45Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Pediatrics Case Reports
spelling doaj.art-9f5d2279a3e3415fadad0b19811208602024-03-25T15:38:28ZengWolters Kluwer Medknow PublicationsIndian Pediatrics Case Reports2772-51702772-51892022-01-0121121610.4103/ipcares.ipcares_12_22Biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothersRanjana MishraMeenakshi Bothra GuptaSharmila B MukherjeeAvinash LomashSangeeta GuptaSeema KapoorBackground: Biotin is the coenzyme of multiple carboxylases involved in gluconeogenesis, fatty acid synthesis, and amino acid catabolism. Biotinidase (BTD) deficiency is an autosomal recessive disorder affecting the biotin cycle. It disrupts endogenous biotin recycling and results in multiple carboxylase deficiency depending upon the level of enzyme activity. Children with profound deficiency often present in infancy with neurocutaneous manifestations. Management of symptomatic children or screen-positive newborns is lifelong oral supplementation with biotin. There may be partial or complete resolution of symptoms in the former. Clinical Description: We describe two unrelated families diagnosed as profound BTD deficiency, with three affected children in each family. The first family had two symptomatic surviving children, a 2-year-old boy with seizures, developmental delay, and hearing loss, and a 1.5-month-old boy with seizures. Diagnosis was established while ascertaining etiology for seizures refractory to multiple anticonvulsant therapy. The second family was referred for postconceptional counseling following two infantile deaths with similar phenotype, early-onset seizures, encephalopathy, and acute metabolic decompensation. Management: The affected children in the first family showed a dramatic response in seizure controls with oral biotin though the other symptoms such as developmental delay and hearing loss remained unaffected. Mother was advised regarding prenatal diagnosis in the next pregnancy but was unwilling. In the second family, stored genetic material from the earlier affected infant revealed a pathogenic homozygous indel in the BTD gene, which was confirmed in utero in the subsequent pregnancy. Both women were started on oral biotin on the lines of antenatal management of holocarboxylase synthetase deficiency. After birth, therapy was continued on the confirmation of profound BTD deficiency in both babies. They have remained asymptomatic on follow-up; the first baby till a year and the second till 3 months. Conclusion: There is a considerable phenotypic variability in profound BTD deficiency. Early detection and prompt treatment with biotin may result in complete resolution of some symptoms and ameliorate others. Antenatal biotin supplementation in families at high risk or with prenatal diagnosis of BTD deficiency may have a favorable outcome in affected progeny.http://www.ipcares.org/article.asp?issn=2772-5170;year=2022;volume=2;issue=1;spage=12;epage=16;aulast=Mishraalopeciaencephalopathyhearing lossmultiple carboxylase deficiencyseizures
spellingShingle Ranjana Mishra
Meenakshi Bothra Gupta
Sharmila B Mukherjee
Avinash Lomash
Sangeeta Gupta
Seema Kapoor
Biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothers
Indian Pediatrics Case Reports
alopecia
encephalopathy
hearing loss
multiple carboxylase deficiency
seizures
title Biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothers
title_full Biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothers
title_fullStr Biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothers
title_full_unstemmed Biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothers
title_short Biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothers
title_sort biotin supplementation in children with symptomatic profound biotinidase deficiency and their pregnant mothers
topic alopecia
encephalopathy
hearing loss
multiple carboxylase deficiency
seizures
url http://www.ipcares.org/article.asp?issn=2772-5170;year=2022;volume=2;issue=1;spage=12;epage=16;aulast=Mishra
work_keys_str_mv AT ranjanamishra biotinsupplementationinchildrenwithsymptomaticprofoundbiotinidasedeficiencyandtheirpregnantmothers
AT meenakshibothragupta biotinsupplementationinchildrenwithsymptomaticprofoundbiotinidasedeficiencyandtheirpregnantmothers
AT sharmilabmukherjee biotinsupplementationinchildrenwithsymptomaticprofoundbiotinidasedeficiencyandtheirpregnantmothers
AT avinashlomash biotinsupplementationinchildrenwithsymptomaticprofoundbiotinidasedeficiencyandtheirpregnantmothers
AT sangeetagupta biotinsupplementationinchildrenwithsymptomaticprofoundbiotinidasedeficiencyandtheirpregnantmothers
AT seemakapoor biotinsupplementationinchildrenwithsymptomaticprofoundbiotinidasedeficiencyandtheirpregnantmothers